Drug Search Results
More Filters [+]

GELESIS-100

Alternative Names: gelesis-100, gelesis100, gelesis 100
Latest Update: 2022-11-01
Latest Update Note: PubMed Publication

Product Description

an oral, non-systemic approach to weight loss

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Gelesis
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for GELESIS-100

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

NCT04257123

N/A

Completed

Overweight|Obesity|Weight Loss

2020-11-30

GLOW-EX

N/A

Completed

Obesity|Overweight

2017-12-08

G-04

N/A

Completed

Obesity|Overweight

2017-06-01

GS-100-006

N/A

Completed

Obesity|Overweight

2016-07-01

Recent News Events